CEREBROLYSIN 60mg

• Mimics natural neurotrophic factors: It functions like endogenous brain growth factors (such as BDNF) to support neuronal survival, health, and signaling.
• Stimulates brain neuroplasticity: It actively promotes neurogenesis and increases the number of synapses to help the brain remodel and self-repair.
• Protects cells against excitotoxicity: The compound shields fragile neurons from free radicals, neuroinflammation, and toxic neurotransmitter overloads.
• Improves global cognitive function: Clinical data demonstrates notable improvements in memory, concentration, and daily functioning for neurodegenerative conditions.
• Aids acute neuro-recovery: Physicians frequently use it as an add-on therapy internationally to accelerate recovery following a stroke or traumatic brain injury.

Cerebrolysin 60 mg — Peptide-Based Neurotrophic Complex for CNS Research

Cerebrolysin is a peptide-based neurotrophic complex composed of
low–molecular weight peptides and amino acids derived from enzymatic protein hydrolysates.
In preclinical and clinical research, Cerebrolysin has been investigated for its potential
effects on neuronal survival, synaptic plasticity, cognitive performance, and
recovery after CNS injury.

What It Is

• Class: Peptide and amino-acid neurotrophic mixture
• Composition: Low–molecular weight peptides & free amino acids
  (exact profile may vary by lot/specification)
• Research focus: Neuroprotection, neuroplasticity, cognition, and
  recovery in central-nervous-system models.

Metabolic & Anti-Inflammatory Pathways

• Used in models assessing oxidative stress, mitochondrial function,
  and apoptotic signaling in neurons.
• Preclinical work includes effects on neuroinflammatory markers
  and glial-cell responses after injury.
• Interest in combined neuroprotective and neurorestorative
  profiles in chronic CNS conditions.

Selected Research Highlights

• Stroke & Ischemia Models: Cerebrolysin has been studied in
  ischemic brain injury for impacts on infarct size, functional recovery,
  and neurologic scores in animal and clinical research.
• Cognitive & Memory Research: Experimental work examines
  learning, memory, and executive-function endpoints in aging and
  disease-related models.
• Neurodegenerative Contexts: Investigated in preclinical and selected
  clinical settings for effects on cognitive decline and neurodegenerative
  markers.